Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 36,029 $ 47,667 [1]
Accounts receivable, net (net of allowance for doubtful accounts of $360 and $260, respectively) 78,424 43,491 [1]
Inventories 58,117 37,925 [1]
Prepaid inventory 5,480 891 [1]
Derivative instruments 12,977 17,149 [1]
Assets held-for-sale 30,158 58,295 [1]
Other current assets 5,413 8,628 [1]
Total current assets 226,598 214,046 [1]
Property and equipment, net 224,319 229,486 [1]
Other Assets:    
Right of use operating lease assets, net 12,715 11,046 [1]
Notes receivable 12,423 14,337 [1]
Intangible assets 2,678 2,678 [1]
Other assets 4,671 5,225 [1]
Total other assets 32,487 33,286 [1]
Total Assets 483,404 476,818 [1]
Current Liabilities:    
Accounts payable – trade 28,387 13,047 [1]
Accrued liabilities 15,455 11,101 [1]
Current portion – operating leases 3,216 2,180 [1]
Current portion – long-term debt 17,687 25,533 [1]
Derivative instruments 2,735  
Liabilities held-for-sale 10,500 19,542 [1]
Other current liabilities 6,468 15,524 [1]
Total current liabilities 84,448 86,927 [1]
Long-term debt, net of current portion 70,621 71,807 [1]
Operating leases, net of current portion 9,365 8,715 [1]
Other liabilities 13,774 13,134 [1]
Total Liabilities 178,208 180,583 [1]
Commitments and Contingencies (Note 7)
Alto Ingredients, Inc. Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2021 and December 31, 2020; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2021 and December 31, 2020; liquidation preference of $20,609 as of September 30, 2021 1 1 [1]
Common stock, $0.001 par value; 300,000 shares authorized; 72,800 and 72,487 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 73 72 [1]
Additional paid-in capital 1,036,608 1,036,638 [1]
Accumulated other comprehensive loss (3,878) (3,878) [1]
Accumulated deficit (727,608) (736,598) [1]
Total Stockholders’ Equity 305,196 296,235 [1]
Total Liabilities and Stockholders’ Equity 483,404 476,818 [1]
Non-Voting Common Stock    
Alto Ingredients, Inc. Stockholders’ Equity:    
Common stock, $0.001 par value; 300,000 shares authorized; 72,800 and 72,487 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2020.